Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Melbourne, Parkville, Victoria, Australia.
Murdoch Children's Research Institute, Melbourne, Parkville, Victoria, Australia.
Pediatr Pulmonol. 2021 Jun;56(6):1490-1495. doi: 10.1002/ppul.25275. Epub 2021 Feb 1.
With the emergence of cystic fibrosis transmembrane conductance regulator (CFTR) modulators, forced expiratory volume in 1 s (FEV ) may become a less sensitive measure of pulmonary disease progression in children with cystic fibrosis (CF). Increasing evidence shows that peak oxygen uptake (VO ) is a strong predictor of prognosis in CF. The primary aim of this study was to describe the associations between peak oxygen uptake, lung function, and bronchiectasis in children with CF in the era of CFTR modulators.
Spirometry and a maximal cardiopulmonary exercise test (CPET) were performed on the same day and compared to markers of disease severity. Markers of disease severity included a number of pulmonary exacerbations resulting in hospital admission within the preceding 12 months, body mass index, Pseudomonas aeruginosa (PsA) infection, and bronchiectasis.
Fifty-two subjects (24 female) with CF participated in the study with a mean (SD) age of 13.8 (2.4) years, range 8-18 years. Forty-nine participants met satisfactory criteria for a maximal CPET. A significant correlation was found between relative VO %predicted and FEV %predicted (r = .546, p < .001). A total of 4/49 children demonstrated an impaired aerobic capacity despite normal spirometry. Participants who had experienced one or more pulmonary exacerbations in the previous 12 months had a significantly lower relative VO %predicted (p = .02).
In children with CF who have mild pulmonary disease, there is significant correlation between FEV and VO . In all, 8.2% of participants had an abnormal CPET result despite normal spirometry, and preceding pulmonary exacerbations were associated with poorer CPET outcomes. CPET may offer important prognostic information for clinical decision making in this new era of CFTR modulators.
随着囊性纤维化跨膜电导调节因子(CFTR)调节剂的出现,1 秒用力呼气量(FEV )可能成为 CF 儿童肺部疾病进展的一个不太敏感的衡量标准。越来越多的证据表明,峰值摄氧量(VO )是 CF 预后的一个强有力的预测指标。本研究的主要目的是描述 CFTR 调节剂时代 CF 儿童的峰值摄氧量、肺功能和支气管扩张之间的关系。
在同一天进行了肺活量测定和最大心肺运动测试(CPET),并与疾病严重程度的标志物进行了比较。疾病严重程度的标志物包括过去 12 个月内因肺部感染而导致住院的次数、体重指数、铜绿假单胞菌(PsA)感染和支气管扩张。
52 名 CF 儿童(24 名女性)参与了这项研究,平均年龄(标准差)为 13.8(2.4)岁,年龄范围为 8-18 岁。49 名参与者的最大 CPET 符合满意标准。相对 VO %预测值与 FEV %预测值之间存在显著相关性(r=0.546,p<0.001)。尽管肺活量测定正常,但仍有 4/49 名儿童的有氧能力受损。过去 12 个月内经历过一次或多次肺部感染的参与者,其相对 VO %预测值显著较低(p=0.02)。
在 CF 儿童中,即使肺疾病较轻,FEV 和 VO 之间也存在显著相关性。总的来说,尽管肺活量测定正常,但仍有 8.2%的参与者 CPET 结果异常,而之前的肺部感染与较差的 CPET 结果相关。CPET 可能为 CFTR 调节剂的新时代提供重要的预后信息,以帮助临床决策。